American University is evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patient
University of Michigan Rogel Cancer Center is starting a new clinical trial of Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients.
This project's overall goal is to test the feasibility, acceptability and efficacy of two coach-assisted, computer-based, cognitive- behavioral therapy (C-CBT) interventions in treating depression and anxiety in adolescent and young adult cancer survivors. The two coach-assisted interventions will be compared to the standard C-CBT intervention.
The clinical trial started in November 30, 2020 and will continue throughout February 2022.
Percentage of participants who confirm acceptability of the intervention during interviews will be primary outcome measure. Participants will be interviewed about their perceptions regarding the delivery format, treatment content, and other treatment related factors. Qualitative interviews will be transcribed by research staff and coded using thematic content analysis and axial coding. Qualitative data will be reviewed iteratively until saturation is reached, that is when no new information seems to emerge during coding. Emergence or non-emergence of acceptability theme will be assessed. Findings will be descriptive and will include the percentage of participants who confirm acceptability.
The inclusion parameters are:
- Cancer survivor, either receiving active treatment or completed cancer treatment
- Experiencing depression and anxiety as measured by PHQ-9 or GAD-7
The contacts and locations are the University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States.
For more details: https://ichgcp.net/clinical-trials-registry/NCT04773197
Clinical Research News
Upcoming Clinical Trials
NCT04847206Not yet recruitingConditions: Healthy
NCT04847232Not yet recruitingEffect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)Conditions: Hyperkalemia
NCT04847245Not yet recruitingEsketamine Adjuvant Therapy for Patients With Chronic Visceral Pain Comorbid Major Depressive DisorderConditions: Chronic Visceral Pain; Major Depressive Disorder
NCT04847271Not yet recruitingConditions: Obesity, Childhood
NCT04847297Not yet recruitingConditions: Pancreatic Cancer
NCT04847310Not yet recruitingCost-effectiveness Evaluation of the Individual vs Group Transdiagnostic Psychological Treatment for Emotional Disorders in Primary CareConditions: Emotional Disorder; Depression; Somatoform Disorders; Anxiety Disorders
NCT04847401Not yet recruitingConditions: Irritable Bowel Syndrome
NCT04847453Not yet recruitingVenetoclax, Ixazomib Citrate and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain AmyloidosisConditions: Recurrent AL Amyloidosis; Refractory AL Amyloidosis
NCT04847466Not yet recruitingA Phase II Study of Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck CancerConditions: Gastroesophageal Junction (GEJ) Cancers; Advanced HNSCC
NCT04847479Not yet recruitingConditions: Covid19